Company news
Decision Diagnostics Corp news in 2018
Decision Diagnostics Corp's news releases, calls and decks from 2018, newest first.
DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)
December 18, 2018
DECN Engages Second Korean Manufacturing Partner to Raise Its Factory Capacity by Two Million Boxes of ''GEN'' Test Strips Annually
December 16, 2018
DECN Releases its Strategic IP And Product Development Introduction Plan With a Summary of 2018 Achievements and 2019 Expectations
December 10, 2018
DECN Receives Completed Clinical Trials Report from its IRB and Anticipates Filing its U.S. FDA 510k Application for its Genchoice! Product on December 21, 2018
December 3, 2018
DECN CEO Keith M. Berman Is Interviewed By Prestigious Wall Street Reporter Who Describe Company And Products As ''Game Changer''
November 26, 2018
DECN Receives Completed Clinical Trial Data, Charts and Spreadsheets Essential for its Imminent Genchoice! Test Strip
November 5, 2018
DECN Set to Appeal the Clearly Unfair Ruling in Court's Termination of the DECN Patent Infringement and False Advertising Case Battle with Johnson & Johnson
October 29, 2018
DECN Board Of Directors In Final Review Of Preliminary Financing Agreement For $4.75 Million Investment
September 12, 2018
DECN Announces Major Step Ahead with Offering Statement
September 5, 2018
DECN Announces Significant Updates For Products And Programs
August 13, 2018
DECN Makes Its Mark In $1+ Billion Dollar Pet Diabetes & Glucose Testing Market With Two New Products, Petsure! & Petultimate!
August 6, 2018
Decision Diagnostics Corp. Announces Election of Two Key Managers to the Board of Its Korean Partner ''The Bio Co, Ltd.''
July 11, 2018
Decision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ)
April 17, 2018
Decision Diagnostics Discusses Culmination of Patent Case Against J&J and Its Divisions Based on The Federal Doctrine of Equivalents
March 26, 2018
Decision Diagnostics' Panacea Genprecis! Product Moves into Pre-Production, First Round Clinical Trials to Begin in the Next 30 Days
March 20, 2018
Decision Diagnostics' Fundamental Genchoice! Diabetic Test Strip Moves into Formal Managed Clinical Trials and Advanced Testing for Upcoming 510k Filing with U.S. FDA
March 12, 2018
Decision Diagnostics Announces 2018 Business Focus Through the Introduction of New Products, Positive Conclusion to J&J Litigation, and Hybrid Private Label Business Model
January 2, 2018